EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Venous thromboembolism: Why is it still a significant health problem?

Monika Oleksiuk-Bójko, Anna Lisowska

Advances in Medical Sciences · 2023-03 · 68 (1) · 10-20

DOI: 10.1016/j.advms.2022.10.002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advances in Medical Sciences, 2023-03. Verfasst von Monika Oleksiuk-Bójko und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, University Clinical Hospital in Bialystok, Bialystok, Poland. Hauptthemen laut MEDLINE: Venous Thromboembolism, COVID-19, Pulmonary Embolism, Myocardial Infarction. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 112 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Venous thromboembolism (VTE) remains the third leading cause of acute cardiovascular syndrome following myocardial infarction and ischemic stroke. The global burden of disease worldwide is high and shows a steady upward trend in recent years with an incidence of 1-2 per 1000 adults per year. The overarching goal of the initial management of VTE is to prevent early and late adverse outcomes. Rapid evaluation and therapeutic intervention is vital to improving prognosis. METHODS: We searched PubMed, Science Direct and Scopus databases for articles published in the last 10 years. Additionally, some earlier articles were analyzed. RESULTS: For the purposes of this review, we discussed how understanding the epidemiology of VTE and the current knowledge of early and late complications of this disease have shaped the current approach to VTE prevention. We also analyzed the current knowledge and the most up-to-date information about VTE in COVID-19 infection. Contemporary perspective presented in this article on mortality in VTE, the incidence of recurrences, the risk of major bleeding during therapy and the chronic complications indicate why this is a major challenge for today's medicine and a current target for further research. CONCLUSIONS: Understanding the interaction between environmental and genetic factors appears to be crucial in the diagnostic process. It can provide insight into the pathophysiology of VTE, potentially identifying options for targeted prevention and treatment. However, due to differences in clinical presentation, diagnosing pulmonary embolism may not be an easy task which perfectly illustrates the scale and complexity of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous ThromboembolismCOVID-19Pulmonary EmbolismMyocardial InfarctionAdultHumansAnticoagulantsRisk Factors

Stichwörter der Autor:innen

COVID-19Deep vein thrombosisEpidemiologyPulmonary embolismVenous thromboembolism

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Cardiology, University Clinical Hospital in Bialystok, Bialystok, Poland.
  • Department of Cardiology, University Clinical Hospital in Bialystok, Bialystok, Poland. Electronic address: anlila@poczta.onet.pl.

Zitieren

APA

Oleksiuk-Bójko, M., & Lisowska, A. (2023). Venous thromboembolism: Why is it still a significant health problem?. Advances in Medical Sciences, 68(1), 10-20. https://doi.org/10.1016/j.advms.2022.10.002

Vancouver

Oleksiuk-Bójko M, Lisowska A. Venous thromboembolism: Why is it still a significant health problem?. Advances in Medical Sciences. 2023;68(1):10-20. doi:10.1016/j.advms.2022.10.002

BibTeX
@article{OleksiukBjko2023,
  author = {Oleksiuk-Bójko, Monika and Lisowska, Anna},
  title = {Venous thromboembolism: Why is it still a significant health problem?},
  journal = {Advances in Medical Sciences},
  year = {2023},
  volume = {68},
  number = {1},
  pages = {10--20},
  doi = {10.1016/j.advms.2022.10.002}
}
Kostenlos starten →